Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Intellia Therapeutics (NTLA) Shares Issued (2016 - 2026)

Intellia Therapeutics has reported Shares Issued over the past 11 years, most recently at $750.0 million for Q1 2026.

  • Quarterly Shares Issued changed N/A to $750.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $766.3 million through Mar 2026, up 338.03% year-over-year, with the annual reading at $2.6 million for FY2025, 98.54% down from the prior year.
  • Shares Issued was $750.0 million for Q1 2026 at Intellia Therapeutics, up from $1.4 million in the prior quarter.
  • Over five years, Shares Issued peaked at $750.0 million in Q1 2026 and troughed at -$386.7 million in Q2 2022.
  • The 5-year median for Shares Issued is $1.4 million (2025), against an average of $90.0 million.
  • Year-over-year, Shares Issued tumbled 773.29% in 2022 and then surged 17511.06% in 2024.
  • A 5-year view of Shares Issued shows it stood at $398.9 million in 2022, then plummeted by 99.75% to $995000.0 in 2023, then surged by 17511.06% to $175.2 million in 2024, then plummeted by 99.23% to $1.4 million in 2025, then skyrocketed by 55373.37% to $750.0 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Shares Issued are $750.0 million (Q1 2026), $1.4 million (Q4 2025), and $1.2 million (Q3 2025).